Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis

Immune-guided therapy of COVID-19

(2022) Gianfranco Ferraccioli et al.   Cancer Immunology Research

Adaptive immunity to SARS-CoV-2 and COVID-19

(2021) Alessandro Sette et al.   CELL

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

(2021) Jennifer M. Dan et al.   SCIENCE

Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases

(2021) Rita Carsetti et al.   Frontiers in Immunology

In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy

(2021) Linda Petrone et al.   JOURNAL OF INFECTION

Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled

(2021) Delia Goletti et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases

(2021) David Simon et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

(2021) Ulf M Geisen et al.   ANNALS OF THE RHEUMATIC DISEASES

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients

(2021) Alessandra Aiello et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus

(2021) Giulia Matusali et al.   Viruses-Basel

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

(2021) Victoria Furer et al.   ANNALS OF THE RHEUMATIC DISEASES

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

(2021) Rebecca H Haberman et al.   ANNALS OF THE RHEUMATIC DISEASES

Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis

(2021) Anuraag Jena et al.   AUTOIMMUNITY REVIEWS

The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses

(2021) Delia Goletti et al.   CLINICAL MICROBIOLOGY AND INFECTION

Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2 specific T cells

(2021) Catherine Riou et al.   EUROPEAN RESPIRATORY JOURNAL

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection

(2021) Elisa Petruccioli et al.   Journal of Translational Medicine

Spike-antibody waning after second dose of BNT162b2 or ChAdOx1

(2021) Madhumita Shrotri et al.   LANCET

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

(2021) Yinon M. Bar-On et al.   NEW ENGLAND JOURNAL OF MEDICINE

In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses

(2021) Saeid Najafi Fard et al.   Biomed Research International

American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3

(2021) Jeffrey R. Curtis et al.   Arthritis & Rheumatology

ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients

(2021) Andrea Picchianti-Diamanti et al.   Frontiers in Immunology

Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine

(2021) Chiara Agrati et al.   Microorganisms

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups

(2021) Clodoveo Ferri et al.   JOURNAL OF AUTOIMMUNITY

Multi-omics approach to COVID-19: a domain-based literature review

(2021) Chiara Montaldo et al.   Journal of Translational Medicine

Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies

(2021) Carla Tortorella et al.   NEUROLOGY

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

(2021) Einav G. Levin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines

(2021) Andrea Picchianti Diamanti et al.   Frontiers in Immunology

BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype

(2021) Gisella Guerrera et al.   Science Immunology

The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2

(2021) Tzu-Chuan Ho et al.   Vaccines

T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

(2021) Adrienn Angyal et al.   Lancet Microbe

The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory

(2020) Ola Grimsholm et al.   Cell Reports

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Interferon-gamma release assay for accurate detection of SARS-CoV-2 T cell response

(2020) Kanagavel Murugesan et al.   CLINICAL INFECTIOUS DISEASES

A whole blood test to measure SARS-CoV-2 specific response in COVID-19 patients

(2020) Linda Petrone et al.   CLINICAL MICROBIOLOGY AND INFECTION

Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review

(2020) Fabrizio Cantini et al.   DRUGS

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dysregulated miR-155 and miR-125b Are Related to Impaired B-cell Responses in Down Syndrome

(2018) Chiara Farroni et al.   Frontiers in Immunology

Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry

(2015) Benjamin M. Kagina et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings

(2015) Diletta Valentini et al.   VACCINE

Global Analyses of Human Immune Variation Reveal Baseline Predictors of Postvaccination Responses

(2014) John S. Tsang et al.   CELL

Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents

(2014) A. Picchianti Diamanti et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Cutting Edge: Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Inhibits Memory B Lymphocytes via Effects on Lymphoid Germinal Centers and Follicular Dendritic Cell Networks

(2014) J. H. Anolik et al.   JOURNAL OF IMMUNOLOGY

Abatacept Reduces Levels of Switched Memory B Cells, Autoantibodies, and Immunoglobulins in Patients with Rheumatoid Arthritis

(2014) M. Scarsi et al.   JOURNAL OF RHEUMATOLOGY

Immunological mechanisms of vaccination

(2011) Bali Pulendran et al.   NATURE IMMUNOLOGY

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) Daniel Aletaha et al.   ARTHRITIS AND RHEUMATISM

How many events is enough? Are you positive?

(2008) Mario Roederer   CYTOMETRY PART A

Phenotypic and functional heterogeneity of human memory B cells

(2008) Iñaki Sanz et al.   SEMINARS IN IMMUNOLOGY